Skip to main content
. 2019 Aug;69(4):311–320. doi: 10.30802/AALAS-CM-18-000089

Table 4.

Antimicrobial susceptibility of MRSA isolates, grouped according to sequence type; data in each column are given as percentage of total isolates

ST188 (total n = 14)
ST3268 (total n = 3)
S I R S I R ST3478 (n = 1) Not typed (n = 1)
Enrofloxacin 0% 0% 100% 0% 0% 100% S S
Ampicillin 7% 0% 93% 0% 0% 100% R R
Ceftriaxone 0% 14% 86% 0% 33% 67% I R
Chloramphenicol 7% 93% 0% 33% 67% 0% I I
Clindamycin 14% 0% 86% 0% 67% 33% S R
Erythromycin 14% 0% 86% 0% 67% 33% S R
Gentamicin 7% 0% 93% 0% 33% 67% R R
Oxacillin 0% 0% 100% 0% 0% 100% R R
Penicillin 7% 0% 93% 0% 0% 100% R R
Rifampin 100% 0% 0% 100% 0% 0% S S
Tetracycline 86% 0% 14% 33% 0% 67% R S
TMS 43% 0% 57% 67% 0% 33% S R
Vancomycin 100% 0% 0% 100% 0% 0% S S

I, intermediate; R, resistant; S, susceptible